Pence says he opposes RFK Jr.’s nomination for HHS secretary because of his stance on abortion
Growth Investment from Marlin Equity Partners to Boost Radar Healthcare’s Expansion
Last Updated on:
Radar Healthcare, a leader in providing risk, quality, and compliance software to healthcare and social care sectors, has received a significant majority investment from Marlin Equity Partners. This support aims to further Radar Healthcare’s objectives of product enhancement and speeding up its international expansion.
Co-founders Paul Johnson and Lee Williams, along with 24Haymarket, Radar Healthcare’s main shareholder since 2017, will continue to hold minority stakes in the firm.
Paul Johnson, Radar Healthcare’s CEO, commented: “We are thrilled to partner with Marlin to accelerate our growth and further enhance our product offering. As the demand for unified systems to support care delivery continues to grow, this investment allows us to scale our solutions to meet the evolving needs of our customers across healthcare and social care. The Marlin team showed a profound understanding of our value proposition and strong alignment with our growth ambitions.”
Marlin Equity Partners shared their enthusiasm for the new venture, with Principal Chris Clasper saying: “The Radar Healthcare team has developed an innovative and customer-centric platform that is uniquely positioned to support the mission-critical needs of healthcare and social care providers. We are excited to work alongside the founders and management team to provide operational and financial resources that will support Radar Healthcare’s continued growth.”
This investment represents a commitment to driving innovation within healthcare and social care, allowing Radar Healthcare to elevate its offerings and extend its influence worldwide.
DWF served as Radar Healthcare’s advisor throughout this transaction.